| Application no. and date | 07861684.4 (espacenet) (Federated) (European Patent Register), 20071102 | | Patent/reg. no. and date | DK/EP 2087001, 20161026 | | Publication date | 20090812 | | Priority no. and date | US 856592 P, 20061102 | | EP pub. no. and date |
EP 2087001 20090812 | | Effective date | | | Applicant/owner | Acceleron Pharma, Inc., 128 Sidney Street
Cambridge, MA 02139, US | | Applicant ref. no. | WGS A0904.70000EP00 | | Inventor | KUMAR, Ravindra, 421 Arlington Street
Acton, MA 01720, US,
KNOPF, John, 147 Robbins Drive
Carlisle, MA 01741, US,
PEARSALL, Robert Scott, 21 Bird Street
Woburn, MA 01801, US,
SEEHRA, Jasbir, 3 Lincoln Terrace
Lexington, MA 02421, US,
GRINBERG, Asya, 12468 Main Campus Drive
Lexington, MA 02421, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07K 14/71 (2006.01) | | Title | ALK1-RECEPTOR- OG LIGANDANTAGONISTER OG ANVENDELSER DERAF | | Int. application no. | US2007023217 | | Int. publication no. | WO2008057461 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
